LPL Financial’s Sanofi Contingent Value Rights GCVRZ Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q1 | – | Sell |
-16,311
| Closed | -$14K | – | 3526 |
|
|
2019
Q4 | $14K | Hold |
16,311
| – | – | ﹤0.01% | 3324 |
|
|
2019
Q3 | $9K | Sell |
16,311
-150
| -0.9% | -$81 | ﹤0.01% | 3278 |
|
|
2019
Q2 | $9K | Sell |
16,461
-216
| -1% | -$108 | ﹤0.01% | 3265 |
|
|
2019
Q1 | $8K | Sell |
16,677
-249
| -1% | -$116 | ﹤0.01% | 3175 |
|
|
2018
Q4 | $8K | Sell |
16,926
-10
| -0.1% | -$5 | ﹤0.01% | 3057 |
|
|
2018
Q3 | $9K | Buy |
16,936
+5,693
| +51% | +$3.05K | ﹤0.01% | 3216 |
|
|
2018
Q2 | $6K | Buy |
+11,243
| New | +$5.24K | ﹤0.01% | 3203 |
|
|
2016
Q2 | – | Sell |
-18,044
| Closed | -$2K | – | 3295 |
|
|
2016
Q1 | $2K | Sell |
18,044
-1,390
| -7% | -$151 | ﹤0.01% | 3099 |
|
|
2015
Q4 | $2K | Buy |
19,434
+9,158
| +89% | +$1.29K | ﹤0.01% | 3158 |
|
|
2015
Q3 | $2K | Buy |
10,276
+199
| +2% | +$68 | ﹤0.01% | 2785 |
|
|
2015
Q2 | $7K | Buy |
+10,077
| New | +$6.97K | ﹤0.01% | 2860 |
|
|
2014
Q4 | – | Sell |
-13,066
| Closed | -$7K | – | 2904 |
|
|
2014
Q3 | $7K | Buy |
13,066
+93
| +0.7% | +$45 | ﹤0.01% | 2691 |
|
|
2014
Q2 | $6K | Sell |
12,973
-794
| -6% | -$384 | ﹤0.01% | 2674 |
|
|
2014
Q1 | $4K | Buy |
13,767
+728
| +6% | +$271 | ﹤0.01% | 2636 |
|
|
2013
Q4 | $4K | Buy |
13,039
+23
| +0.2% | +$28 | ﹤0.01% | 2643 |
|
|
2013
Q3 | $26K | Sell |
13,016
-207
| -2% | -$394 | ﹤0.01% | 2515 |
|
|
2013
Q2 | $25K | Buy |
+13,223
| New | +$23.2K | ﹤0.01% | 2393 |
|
LPL Financial's GCVRZ Position: Q1 2020 in Review
LPL Financial sold out of Sanofi Contingent Value Rights (GCVRZ) in Q1 2020, closing a stake of 16,311 shares — an estimated $14K sold.
LPL Financial first reported a position in GCVRZ in Q2 2013 and held it in 17 quarters. The position peaked at $26K in Q3 2013. 2 funds tracked by Wall St. Rank hold GCVRZ as of Q1 2020.
- LPL Financial reported no remaining Sanofi Contingent Value Rights position as of Q1 2020 after selling out during the quarter.
- LPL Financial sold 16,311 Sanofi Contingent Value Rights shares in Q1 2020, an estimated $14K.
- LPL Financial first reported a position in Sanofi Contingent Value Rights in Q2 2013 and held it in 17 quarters.
- LPL Financial's Sanofi Contingent Value Rights position peaked at $26K in Q3 2013.
- 2 funds tracked by Wall St. Rank held Sanofi Contingent Value Rights as of Q1 2020.
Based on LPL Financial's 13F filing for Q1 2020, filed 14 May 2020.